.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The FLORALI randomised trial compared high-flow nasal oxygen, standard oxygen and noninvasive ventilation in adults with nonhypercapnic acute hypoxaemic respiratory failure. Although the primary outcome of intubation rate did not differ significantly among the groups, patients receiving high-flow oxygen had more ventilator-free days and lower 90-day mortality than those receiving standard oxygen or noninvasive ventilation in the trial population. The study helped establish high-flow nasal oxygen as an important option in acute hypoxaemic respiratory failure. Its benefits likely extend beyond oxygen delivery alone, including improved comfort, humidification and washout of upper-airway dead space. For HCPs, the key message is that high-flow oxygen is not simply “more oxygen.” It is a form of respiratory support that should be monitored for work of breathing, gas exchange and clinical trajectory. Delayed intubation remains a potential hazard when non-invasive support creates a false sense of stability. The paper fits CritiCARE 2026 sessions on non-invasive ventilation, respiratory critical care and escalation decisions. Clinicians should combine physiological assessment with frequent reassessment rather than waiting for a single numerical threshold before deciding whether support is succeeding.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The FLORALI randomised trial compared high-flow nasal oxygen, standard oxygen and noninvasive ventilation in adults with nonhypercapnic acute hypoxaemic respiratory failure. Although the primary outcome of intubation rate did not differ significantly among the groups, patients receiving high-flow oxygen had more ventilator-free days and lower 90-day mortality than those receiving standard oxygen or noninvasive ventilation in the trial population. The study helped establish high-flow nasal oxygen as an important option in acute hypoxaemic respiratory failure. Its benefits likely extend beyond oxygen delivery alone, including improved comfort, humidification and washout of upper-airway dead space. For HCPs, the key message is that high-flow oxygen is not simply “more oxygen.” It is a form of respiratory support that should be monitored for work of breathing, gas exchange and clinical trajectory. Delayed intubation remains a potential hazard when non-invasive support creates a false sense of stability. The paper fits CritiCARE 2026 sessions on non-invasive ventilation, respiratory critical care and escalation decisions. Clinicians should combine physiological assessment with frequent reassessment rather than waiting for a single numerical threshold before deciding whether support is succeeding.
last month
A study demonstrates an explainable machine learning framework integrating clinical and echocardiographic metrics to predict left atrial appendage thrombus in non-valvular atrial fibrillation, utilizing SHAP analysis for clinical interpretability.
3 days back
A systematic review and transcriptomic cross-study consensus analysis illuminates the role of necroptosis in cervical cancer. By promoting anti-tumor immunogenicity and resolving apoptosis resistance, necroptotic pathways offer actionable prognostic signatures and promising avenues for combination immunotherapy.
Yesterday
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
Last week
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week
